Home / Inspections / 1322600

FDA Inspection 1322600 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3006468609

The FDA completed an inspection of Octapharma Plasma, Inc. on May 15, 2026 in Wichita, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 15, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Wichita, KS (United States)

Facility

Other inspections at this facility

  • 1153683 (NAI Thu Sep 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1008990 (NAI Thu Mar 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 916482 (NAI Thu Mar 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 757171 (NAI Thu Dec 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 649786 (NAI Wed Mar 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources